{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:04:40Z","timestamp":1760043880955},"reference-count":33,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2406,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0404.1985.tb03176.x","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T20:42:19Z","timestamp":1280004139000},"page":"127-132","source":"Crossref","is-referenced-by-count":13,"title":["Indole levels in human lumbar and ventricular cerebrospinal fluid and the effect of L-tryptophan administration"],"prefix":"10.1155","volume":"71","author":[{"given":"M.","family":"Koskiniemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kuurne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Laipio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"H\u00e4rk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/brain\/93.2.357","article-title":"Cerebral metabolities in cerebrospinal fluid as a biochemical approach to the brain","volume":"93","author":"Moir","year":"1970","journal-title":"Brain"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB2|cit2","first-page":"473476","article-title":"Amines, anticon-vulsants and epilepsy","volume":"1","author":"Chadwick","year":"1975","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1192\/bjp.138.3.257","article-title":"Monoamines in affective illness. Is there a place for 5-HT","volume":"138","author":"Eccleston","year":"1981","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jnnp.30.2.163","article-title":"Estimation of 5-hydroxytryptamine (5-HT) level in cerebrospinal fluid of patients with intracranial and spinal lesions","volume":"30","author":"Misra","year":"1967","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jnnp.39.3.239","article-title":"Relationship between rat brain and cisternal CSF tryptophan concentrations","volume":"39","author":"Young","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1471-4159.1976.tb01520.x","article-title":"Transmitter precursors and metabolites in human ventricular cerebrospinal fluid","volume":"26","author":"Curzon","year":"1976","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jnnp.43.5.438","article-title":"Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs","volume":"43","author":"Young","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(74)90562-9","article-title":"Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies","volume":"79","author":"Garelis","year":"1974","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/00365518309168432","article-title":"Simultaneous determination of tryptophan and its 5-hydroxy-metabolites in human cerebrospinal fluid by reversed phase liquid chromatography with electrochemical detection","volume":"43","author":"Laakso","year":"1983","journal-title":"Scand J Clin Lab Invest"},{"issue":"suppl 149","key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB10|cit10","article-title":"Continuous recording and control of ventricular fluid pressure in neurosurgical practice","volume":"36","author":"Lundberg","year":"1960","journal-title":"Acta Psychiatr Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0009-8981(73)90195-2","article-title":"A method for the estimation of free and total acid-soluble plasma tryptophan using an ultrafiltration technique","volume":"48","author":"Eccleston","year":"1973","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1476-5381.1970.tb10373.x","article-title":"Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain","volume":"39","author":"Curzon","year":"1970","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0009-8981(69)90383-0","article-title":"Fluorimetric determination 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid","volume":"26","author":"Korf","year":"1969","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.1968.tb11648.x","article-title":"Measurement of acid monoamine metabolites in human an animal cerebrospinal fluid","volume":"15","author":"Gerbode","year":"1968","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.42.1.78","article-title":"Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalus","volume":"42","author":"Kmieciak-Kolada","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0009-8981(79)90399-1","article-title":"A column chrom-atographic method for the determination of 5-hydroxytryptamine (serotonin) and 5-hydroxyindole acetic acid in cerebrospinal fluid","volume":"92","author":"Kemerer","year":"1979","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.1984.tb07804.x","article-title":"Monoamine metabolites in human cerebrospinal fluid. HPLC\/ED method","volume":"69","author":"Mean","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.1984.tb02756.x","article-title":"Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects","volume":"42","author":"Hagenfeldt","year":"1984","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1159\/000114710","article-title":"Homovanillic acid and 5-hydroxyindoleacetic acid in the CSF of patients after severe head injury","volume":"13","author":"Morselli","year":"1975","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB20|cit20","first-page":"260","article-title":"1n nurve methode vir bepaling von serotonien in bloed en sereprospinal vlocistof","volume":"55","author":"Kriek","year":"1979","journal-title":"S Afr Med J"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/brain\/97.1.655","article-title":"Disordered neurotransmitter function. Demonstration by measurement of norepinephrine and 5-hydroxytryptamine in CSF of patients with recent cerebral infarction","volume":"97","author":"Meyer","year":"1974","journal-title":"Brain"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(72)91123-3","article-title":"Tryptophan concentration in the cerebrospinal fluid of depressive patients","volume":"1","author":"Coppen","year":"1972","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0404.1980.tb03002.x","article-title":"Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy","volume":"62","author":"Leino","year":"1980","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(80)90020-9","article-title":"Deficient intestinal absorption of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies","volume":"47","author":"Koskiniemi","year":"1980","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410010304","article-title":"Serotonin metabolism in human epilepsy: the influence of anticonvulsant drugs","volume":"1","author":"Chadwick","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0028-3908(79)90147-3","article-title":"Effect of valproic acid on serotonin metabolism","volume":"18","author":"Hwang","year":"1979","journal-title":"Neuropharmacology"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.1981.tb00778.x","article-title":"Monoamine metabolites in successive samples of spinal fluid","volume":"63","author":"Andersen","year":"1981","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410080106","article-title":"Age affect on dopamine and serotonin metabolite levels in cerebrospinal fluid","volume":"8","author":"Seifert","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB29|cit29","first-page":"19","article-title":"Control of brain serotonin by the diet","volume":"5","author":"Wurtman","year":"1974","journal-title":"Adv Neurol"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-86-3-337","article-title":"Treatment of brain disease with dietary precursors of neurotransmitters","volume":"86","author":"Growdon","year":"1977","journal-title":"Ann Intern med"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpsyc.1980.01780230031004","article-title":"Aberrant monoamine metabolite levels in CSF and family history of schizophrenia","volume":"37","author":"Sedvall","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB32|cit32","first-page":"137","article-title":"Biogenic amine disturbances in cerebrospinal fluid in parkinsonims and unipolar depression: use of the probenecid method","volume":"7","author":"Vanderheyden","year":"1981","journal-title":"Neuro-psychobiology"},{"key":"10.1111\/j.1600-0404.1985.tb03176.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cpt1973142277","article-title":"Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline","volume":"14","author":"\u00c5sberg","year":"1973","journal-title":"Clin Pharmacol Ther"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1985.tb03176.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1985.tb03176.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:45:22Z","timestamp":1671540322000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1985.tb03176.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":33,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1985.tb03176.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}